The oncogenic role of SOX8 in endometrial carcinoma

References

• Siegel RL, Miller KD, Jemal A. 2020. Cancer statistics, 2020. CA Cancer J Clin. doi:10.3322/caac.21590
   Web of Science ®Google Scholar
• Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E. Endometrial cancer. Lancet (London, England). 2016;387:1094–1108. doi:10.1016/S0140-6736(15)00130-0.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, PD B, Zhang S, Zeng H, Bray F, Jemal A, XQ Y, He J. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–132.
   PubMed Web of Science ®Google Scholar
• McDonald ME, Bender DP. Endometrial cancer: obesity, genetics, and targeted agents. Obstet Gynecol Clin North Am. 2019;46(1):89–105. doi:10.1016/j.ogc.2018.09.006.
   PubMed Web of Science ®Google Scholar
• Njølstad TS, Trovik J, Hveem TS, Kjæreng ML, Kildal W, Pradhan M, Marcickiewicz J, Tingulstad S, Staff AC, Haugland HK, et al. DNA ploidy in curettage specimens identifies high-risk patients and lymph node metastasis in endometrial cancer. Br J Cancer. 2015;112(10):1656–1664. doi:10.1038/bjc.2015.123.
   PubMed Web of Science ®Google Scholar
• Sinclair AH, Berta P, Palmer MS, Hawkins JR, Griffiths BL, Smith MJ, Foster JW, Frischauf A-M, Lovell-Badge R, Goodfellow PN, et al. A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature. 1990;346(6281):240–244. doi:10.1038/346240a0.
   PubMed Web of Science ®Google Scholar
• Gubbay J, Collignon J, Koopman P, Capel B, Economou A, Munsterberg A, Vivian N, Goodfellow P, Lovell-Badge R. A gene mapping to the sex-determining region of the mouse Y chromosome is a member of a novel family of embryonically expressed genes. Nature. 1990;346(6281):245–250. doi:10.1038/346245a0.
   PubMed Web of Science ®Google Scholar
• Bowles J, Schepers G, Koopman P. Phylogeny of the SOX family of developmental transcription factors based on sequence and structural indicators. Dev Biol. 2000;227(2):239–255. doi:10.1006/dbio.2000.9883.
   PubMed Web of Science ®Google Scholar
• Grimm D, Bauer J, Wise P, Kruger M, Simonsen U, Wehland M, Infanger M, Corydon TJ. The role of SOX family members in solid tumours and metastasis. Semin Cancer Biol. 2019. doi:10.1016/j.semcancer.2019.03.004.
   PubMed Web of Science ®Google Scholar
• Xu YR, Yang WX. SOX-mediated molecular crosstalk during the progression of tumorigenesis. Semin Cell Dev Biol. 2017;63:23–34. doi:10.1016/j.semcdb.2016.07.028.
   PubMed Web of Science ®Google Scholar
• Hu J, Li K, Li Z, Gao C, Guo F, Wang Y, Xue F. Sex-determining region Y box-containing genes: regulators and biomarkers in gynecological cancers. Cancer Biol Med. 2019;16:462–474.
   PubMed Web of Science ®Google Scholar
• Gong B, Yue Y, Wang R, Zhang Y, Jin Q, Zhou X. Overexpression of microRNA-194 suppresses the epithelial-mesenchymal transition in targeting stem cell transcription factor Sox3 in endometrial carcinoma stem cells. Tumour Biol. 2017;39:1010428317706217. doi:10.1177/1010428317706217.
   Google Scholar
• Huang YW, Liu JC, Deatherage DE, Luo J, Mutch DG, Goodfellow PJ, Miller DS, Huang TH. Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancer. Cancer Res. 2009;69:9038–9046. doi:10.1158/0008-5472.CAN-09-1499.
   PubMed Web of Science ®Google Scholar
• Chang L, Yuan Z, Shi H, Bian Y, Guo R. miR-145 targets the SOX11 3ʹUTR to suppress endometrial cancer growth. Am J Cancer Res. 2017;7:2305–2317.
   PubMed Web of Science ®Google Scholar
• Chan DW, Mak CS, Leung TH, Chan KK, Ngan HY. Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancer. Oncotarget. 2012;3:1546–1556. doi:10.18632/oncotarget.667.
   PubMedGoogle Scholar
• Rui X, Xu Y, Jiang X, Guo C, Jiang J. 2017. SOX15 regulates proliferation and migration of endometrial cancer cells. Biosci Rep. 37. DOI:10.1042/BSR20171045
   PubMed Web of Science ®Google Scholar
• Zhang Y, Bao W, Wang K, Lu W, Wang H, Tong H, Wan X. SOX17 is a tumor suppressor in endometrial cancer. Oncotarget. 2016;7(46):76036–76046. doi:10.18632/oncotarget.12582.
   PubMedGoogle Scholar
• Pfeifer D, Poulat F, Holinski-Feder E, Kooy F, Scherer G. The SOX8 gene is located within 700 kb of the tip of chromosome 16p and is deleted in a patient with ATR-16 syndrome. Genomics. 2000;63(1):108–116. doi:10.1006/geno.1999.6060.
   PubMed Web of Science ®Google Scholar
• Zhang S, Zhu C, Zhu L, Liu H, Liu S, Zhao N, Wu J, Huang X, Zhang Y, Jin J, et al. Oncogenicity of the transcription factor SOX8 in hepatocellular carcinoma. Med Oncol (Northwood, London, England). 2014;31(4):918. doi:10.1007/s12032-014-0918-3.
   PubMed Web of Science ®Google Scholar
• Xie C, Han Y, Liu Y, Han L, Liu J. miRNA-124 down-regulates SOX8 expression and suppresses cell proliferation in non-small cell lung cancer. Int J Clin Exp Pathol. 2014;7:7518–7526.
   PubMed Web of Science ®Google Scholar
• Wang Y, Yang W, Liu T, Bai G, Liu M, Wang W. Over-expression of SOX8 predicts poor prognosis in colorectal cancer: A retrospective study. Medicine. 2019;98:e16237. doi:10.1097/MD.0000000000016237.
   PubMed Web of Science ®Google Scholar
• Tang H, Chen B, Liu P, Xie X, He R, Zhang L, Huang X, Xiao X, Xie X. SOX8 acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer. Carcinogenesis. 2019. doi:10.1093/carcin/bgz034.
   Web of Science ®Google Scholar
• Xie SL, Fan S, Zhang SY, Chen WX, Li QX, Pan GK, Zhang H-Q, Wang -W-W, Weng B, Zhang Z, et al. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway. Int J Cancer. 2018;142:1252–1265. doi:10.1002/ijc.31134.
   PubMed Web of Science ®Google Scholar
• Dou Y, Kawaler EA, Cui Zhou D, Gritsenko MA, Huang C, Blumenberg L, Karpova A, Petyuk VA, Savage SR, Satpathy S, et al. Proteogenomic characterization of endometrial carcinoma. Cell. 2020;180(4):729–48.e26. doi:10.1016/j.cell.2020.01.026.
   PubMed Web of Science ®Google Scholar
• Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R, Benz CC, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497:67–73. doi:10.1038/nature12113 7447 497 4164-73
   Google Scholar
• Chen H, Wang Y, Xue F. Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/beta-catenin pathway. Oncol Rep. 2013;29:507–514. doi:10.3892/or.2012.2126.
   PubMed Web of Science ®Google Scholar
• Gao Y, Liu T, Huang Y. MicroRNA-134 suppresses endometrial cancer stem cells by targeting POGLUT1 and Notch pathway proteins. FEBS Lett. 2015;589:207–214. doi:10.1016/j.febslet.2014.12.002.
   PubMed Web of Science ®Google Scholar
• Jonusiene V, Sasnauskiene A, Lachej N, Kanopiene D, Dabkeviciene D, Sasnauskiene S, Kazbariene B, Didziapetriene J. Down-regulated expression of Notch signaling molecules in human endometrial cancer. Med Oncol. 2013;30(1):438. doi:10.1007/s12032-012-0438-y.
   PubMed Web of Science ®Google Scholar
• Mitsuhashi Y, Horiuchi A, Miyamoto T, Kashima H, Suzuki A, Shiozawa T. Prognostic significance of Notch signalling molecules and their involvement in the invasiveness of endometrial carcinoma cells. Histopathology. 2012;60(5):826–837. doi:10.1111/j.1365-2559.2011.04158.x.
   PubMed Web of Science ®Google Scholar
• Kormish JD, Sinner D, Zorn AM. Interactions between SOX factors and Wnt/beta-catenin signaling in development and disease. Dev Dyn. 2010;239:56–68.
   PubMed Web of Science ®Google Scholar
• Tian W, Zhu Y, Wang Y, Teng F, Zhang H, Liu G, Ma X, Sun D, Rohan T, Xue F, et al. Visfatin, a potential biomarker and prognostic factor for endometrial cancer. Gynecol Oncol. 2013;129(3):505–512. doi:10.1016/j.ygyno.2013.02.022.
   PubMed Web of Science ®Google Scholar
• Wang Y, Hu L, Ji P, Teng F, Tian W, Liu Y, Cogdell D, Liu J, Sood AK, Broaddus R, et al. MIIP remodels Rac1-mediated cytoskeleton structure in suppression of endometrial cancer metastasis. J Hematol Oncol. 2016;9(1):112. doi:10.1186/s13045-016-0342-6.
   PubMedGoogle Scholar
• Wang Y, Gao C, Zhang Y, Gao J, Teng F, Tian W, Yang W, Yan Y, Xue F. Visfatin stimulates endometrial cancer cell proliferation via activation of PI3K/Akt and MAPK/ERK1/2 signalling pathways. Gynecol Oncol. 2016;143(1):168–178. doi:10.1016/j.ygyno.2016.07.109.
   PubMed Web of Science ®Google Scholar
• Wang H, Wang H, Shen W, Huang H, Hu L, Ramdas L, Zhou YH, Liao WS, Fuller GN, Zhang W. Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes. Cancer Res. 2003;63:4315–4321.
   PubMed Web of Science ®Google Scholar